Sam G Michael
Overview
Explore the profile of Sam G Michael including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee L, Coelho D, Manzoor N, Wilcox A, Lee A, Graves A, et al.
Otol Neurotol Open
. 2024 Jun;
4(2):e051.
PMID: 38919767
Objective: Determine the incidence of vestibular disorders in patients with SARS-CoV-2 compared to the control population. Study Design: Retrospective. Setting: Clinical data in the National COVID Cohort Collaborative database (N3C)....
2.
Sidky H, Hansen K, Girvin A, Hotaling N, Michael S, Gersing K, et al.
Comput Struct Biotechnol J
. 2024 Feb;
24:115-125.
PMID: 38318198
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their...
3.
Tachinardi U, Grannis S, Michael S, Misquitta L, Dahlin J, Sheikh U, et al.
Learn Health Syst
. 2024 Jan;
8(1):e10404.
PMID: 38249841
Introduction: Research driven by real-world clinical data is increasingly vital to enabling learning health systems, but integrating such data from across disparate health systems is challenging. As part of the...
4.
Sidky H, Sahner D, Girvin A, Hotaling N, Michael S, Gersing K
medRxiv
. 2022 Nov;
PMID: 36380766
Importance: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their...
5.
Kalish H, Klumpp-Thomas C, Hunsberger S, Baus H, Fay M, Siripong N, et al.
Sci Transl Med
. 2021 Jun;
13(601).
PMID: 34158410
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to poorly defined viral prevalence rates in the United States and elsewhere. To address this, we analyzed seropositivity in 9089...
6.
Kalish H, Klumpp-Thomas C, Hunsberger S, Baus H, Fay M, Siripong N, et al.
medRxiv
. 2021 Feb;
PMID: 33532807
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to poorly defined viral prevalence rates. To address this, we analyzed seropositivity in US adults who have not previously been...
7.
Gorshkov K, Chen C, Bostwick R, Rasmussen L, Tran B, Cheng Y, et al.
ACS Infect Dis
. 2020 Dec;
7(6):1389-1408.
PMID: 33346633
Understanding the SARS-CoV-2 virus' pathways of infection, virus-host-protein interactions, and mechanisms of virus-induced cytopathic effects will greatly aid in the discovery and design of new therapeutics to treat COVID-19. Chloroquine...
8.
Haendel M, Chute C, Bennett T, Eichmann D, Guinney J, Kibbe W, et al.
J Am Med Inform Assoc
. 2020 Aug;
28(3):427-443.
PMID: 32805036
Objective: Coronavirus disease 2019 (COVID-19) poses societal challenges that require expeditious data and knowledge sharing. Though organizational clinical data are abundant, these are largely inaccessible to outside researchers. Statistical, machine...